Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-02-07
1987-07-14
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
424 83, A61K 4502, A61K 31745
Patent
active
046801758
ABSTRACT:
An interferon preparation to be administered topically is provided comprising: (a) a therapeutically effective amount of one or more interferons; (b) a vehicle base compatible with the interferon or interferons being administered; (c) an effective amount of one or more protease inhibitors for the purpose of reducing the rate of decay of the biological activity of the interferon or interferons due to proteolytic agents; and (d) an effective amount of one or more anti-microbial agents. In certain preferred embodiments of the invention, the vehicle base is prepared from a mixture of polyethylene glycols or includes hydroxyethyl cellulose as a thickening agent.
REFERENCES:
patent: 4348384 (1982-09-01), Horikoshi et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4507281 (1985-03-01), Asculai et al.
Remington's Pharmaceutical Sciences, 15th Ed., (Arthur Osol, Ed.), Mack Pub. Co., Easton, PA, 1975, pp. 1243-1253.
Mihalyi, E., Appl. of Proteolytic Enzymes to Protein Structure Studies vol. 1, 2d ed, CRC Press, Boca Raton, FL, 1978, pp. 43-54 and 114-127.
Moller et al., Third Annual International Congress for Interferon Research, 1982.
Estis Leonard F.
Evans Sean A.
Testa Douglas
Hazel Blondel
Interferon Sciences, Inc.
Pirri Vincent P.
LandOfFree
Interferon administration vehicles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interferon administration vehicles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon administration vehicles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1426987